世界最新医学信息文摘（电子版）
世界最新醫學信息文摘（電子版）
세계최신의학신식문적（전자판）
World Latest Medicine Information
2014年
4期
5-6
,共2页
脑梗死%低分子肝素%纳洛酮%临床疗效
腦梗死%低分子肝素%納洛酮%臨床療效
뇌경사%저분자간소%납락동%림상료효
infarction%low molecular weight heparin%naloxone%clinical efficacy
目的：探讨低分子肝素与纳洛酮联合治疗脑梗死的临床疗效。方法收集2011年1月至2013年10月，我院收治的脑梗死患者76例，随机分为观察组与对照组，对照组应用低分子肝素治疗，观察组在对照组的基础上加用纳洛酮治疗，比较两组的临床疗效。结果观察组的临床治疗总有效率为94.7%，显著高于对照组的71.1%（P<0.05）；两组治疗后的 niHss 评分均显著降低，但治疗后1周及2周时，观察组的 niHss 显著低于对照组（P<0.05）。结论肝素与纳洛酮联合治疗脑梗死可有效改善患者的神经功能缺损症状，疗效显著，值得推广应用。
目的：探討低分子肝素與納洛酮聯閤治療腦梗死的臨床療效。方法收集2011年1月至2013年10月，我院收治的腦梗死患者76例，隨機分為觀察組與對照組，對照組應用低分子肝素治療，觀察組在對照組的基礎上加用納洛酮治療，比較兩組的臨床療效。結果觀察組的臨床治療總有效率為94.7%，顯著高于對照組的71.1%（P<0.05）；兩組治療後的 niHss 評分均顯著降低，但治療後1週及2週時，觀察組的 niHss 顯著低于對照組（P<0.05）。結論肝素與納洛酮聯閤治療腦梗死可有效改善患者的神經功能缺損癥狀，療效顯著，值得推廣應用。
목적：탐토저분자간소여납락동연합치료뇌경사적림상료효。방법수집2011년1월지2013년10월，아원수치적뇌경사환자76례，수궤분위관찰조여대조조，대조조응용저분자간소치료，관찰조재대조조적기출상가용납락동치료，비교량조적림상료효。결과관찰조적림상치료총유효솔위94.7%，현저고우대조조적71.1%（P<0.05）；량조치료후적 niHss 평분균현저강저，단치료후1주급2주시，관찰조적 niHss 현저저우대조조（P<0.05）。결론간소여납락동연합치료뇌경사가유효개선환자적신경공능결손증상，료효현저，치득추엄응용。
Objective to investigate the clinical efficacy of low molecular weight heparin and naloxone combination therapy of cerebral infarction. Methods 76 patients with cerebral infarction January from January 2011 to October 2013 in our hospital were randomly divided into observation group and control group, the control group of low molecular weight heparin, on the basis of the observation group on the use of the control group naloxone treatment, the clinical efficacy of two groups were compared. Results The clinical observation group, the total effective rate was 94.7%, significantly higher than the 71.1% (P<0.05); After treatment, the NIHSS scores were significantly lower, but after one week of treatment and two weeks to observe NIHSS group was significantly lower than the control group (P<0.05). Conclusion Heparin and naloxone combination therapy is effective in improving cerebral neurological deficit symptoms, a significant effect should be widely applied.
